I was knda just talking about that at the swamp.
Posted by: BooDog
In reply to: zandant who wrote msg# 253839 Date:1/10/2019 1:21:19 PM
Post #253841 of 253844
In its goal to build a world-class clinical asset across the Brilacidin franchise, with the indication of severe OM a Company priority, Innovation Pharmaceuticals is preparing to seek scientific advice from the European Medicines Agency to round out European Union program requirements for Phase 3 clinical trials.
Follow through mutes the last 4 years imo.
Really I don't get emotional about these. If I win, we all win and the patients win. I'm maintaining a position until there is no "hope".
If history, MY history repeats, as soon as I sell, news hits and the train leaves without me. My risk tolerance is pretty high, not just because this is an OTC but also a Bio. The science for both kevetrin and brilacidin is pretty sound imo.